ABIVAX Société Anonyme (EPA:ABVX)
96.60
-4.40 (-4.36%)
At close: Jan 28, 2026
ABIVAX Société Anonyme Revenue
ABIVAX Société Anonyme had revenue of 639.00K EUR in the quarter ending September 30, 2025, a decrease of -88.61%. This brings the company's revenue in the last twelve months to 5.31M, down -42.89% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.
Revenue (ttm)
5.31M
Revenue Growth
-42.89%
P/S Ratio
1,415.63
Revenue / Employee
79.27K
Employees
67
Market Cap
7.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.79M | 6.22M | 135.94% |
| Dec 31, 2023 | 4.57M | 69.00K | 1.53% |
| Dec 31, 2022 | 4.51M | 302.00K | 7.19% |
| Dec 31, 2021 | 4.20M | 4.19M | 29,921.43% |
| Dec 31, 2020 | 14.00K | 21.00K | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 179.91M |
| Cellectis | 70.36M |
| Genfit | 45.13M |
| MedinCell | 32.44M |
| Inventiva | 16.97M |
| Adocia | 12.88M |
| Innate Pharma | 12.64M |
| Nanobiotix | 10.16M |
ABIVAX Société Anonyme News
- 8 days ago - Eli Lilly (LLY) Denies Acquisition Talks with Abivax (ABVX) - GuruFocus
- 8 days ago - Abivax CEO responds to Lilly acquisition rumors - Seeking Alpha
- 8 days ago - Abivax CEO dismisses 'noise' around rumored Eli Lilly bid - Reuters
- 9 days ago - Prediction: This Healthcare Stock Could Soar by 72% in 2026 - The Motley Fool
- 14 days ago - Abivax's Options: A Look at What the Big Money is Thinking - Benzinga
- 16 days ago - Abivax: Don't Just Buy The Rumor, Buy The Fundamentals - Seeking Alpha
- 16 days ago - Eli Lilly (LLY) Considers $17.5B Acquisition of Abivax - GuruFocus
- 16 days ago - Abivax (ABVX) Shares Surge on Potential Eli Lilly Acquisition - GuruFocus